Skip to main content

Table 1 Comparison of patient characteristics

From: Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice

  SMI/AP-only group
n = 1383
SMI/AP + DM group
n = 206
SMI/AP + CVD group
n = 116
Total sample
n = 1705
Sex female 720 (52.1) 110 (53.4) 51 (44.0) 881 (51.7)
Mean age in years (SD) 44.9 (14.8) 58.5 (14.0) 61.8 (12.3) 47.7 (15.7)
SMI diagnosis, total 629 (45.5) 97 (47.1) 48 (41.4) 834 (48.9)
 Schizophrenia 197 (14.2) 38 (18.4) 15 (12.9) 250 (14.7)
 Affective Psychosis/Bipolar Disorder 217 (15.7) 34 (16.5) 24 (20.7) 275 (16.1)
 Psychosis Not Otherwise Specified 307 (22.2) 28 (13.6) 11 (9.5) 346 (20.3)
SMI/AP
 SMI with AP 290 (21.0) 55 (26.7) 20 (17.2) 365 (21.4)
 SMI without AP 399 (28.9) 42 (20.4) 28 (24.1) 469 (27.5)
 AP without SMI 630 (45.6) 95 (46.1) 60 (51.7) 785 (46.0)
 Only lithium 64 (4.6) 14 (6.8) 8 (6.9) 86 (5.1)
Medication use
 Antipsychotics, total 920 (66.5) 150 (72.8) 80 (69.0) 1150 (67.4)
 Lithium 160 (11.6) 31 (15.0) 22 (19.0) 213 (12.5)
 Antidepressants 558 (40.3) 91 (44.2) 58 (50) 707 (41.5)
 CVR lowering medication 295 (21.3) 186 (90.3) 103 (88.8) 584 (34.3)
Comorbidity
 COPD 65 (4.7) 25 (12.1) 23 (19.8) 113 (6.6)
 Alcohol abuse 68 (4.9) 19 (9.2) 12 (10.3) 99 (5.8)
 Tobacco abuse 233 (16.8) 83 (40.3) 42 (36.2) 358 (21.0)
 Drug abuse 101 (7.3) 3 (1.5) 2 (1.7) 106 (6.2)
Number of visits FP /year
 0 393 (28.4) 46 (22.3) 25 (21.6) 464 (27.2)
 1–5 565 (40.9) 60 (29.1) 27 (23.3) 652 (38.2)
 6–10 234 (16.9) 41 (19.9) 27 (23.3) 302 (17.7)
  > 10 191 (13.8) 59 (28.6) 37 (31.09) 287 (16.8)
  1. Values are shown as n (%) unless otherwise noted
  2. SMI Serious Mental Illness, AP Antipsychotics, DM Diabetes Mellitus, CVD Cardiovascular Disease, CVR Cardiovascular Risk, FP Family practice, COPD chronic obstructive pulmonary disease